Case Study: Clinilabs achieves streamlined Phase I trial execution with Medrio's integrated CDMS/EDC & RTSM

How Clinilabs Supports Phase I Trials with Integrated CDMS/EDC & RTSM

Clinilabs, a CNS-focused CRO supporting drug, device, and technology development from first-in-human to Phase III trials, needed a reliable CDMS/EDC and RTSM for a multi-site Phase I psychedelic medication study with complex eligibility and custom requirements. They selected Medrio’s integrated CDMS/EDC and RTSM platform for its ability to integrate seamlessly and provide consultative, hands-on support.

Medrio delivered the integrated platform plus configuration and integration assistance, coordinating workflows across sponsor, sites, and the depot vendor. As a result, Clinilabs achieved streamlined data flow across sites and the depot, faster study builds, UAT and mid-study changes, and greater flexibility and usability for study teams—benefits Clinilabs attributes directly to Medrio’s responsive support and adaptable product.

Clinilabs

Henry Enyenihi

Senior Clinical Data Manager